Deciphera Pharmaceuticals, Inc. Foreign Pre-Tax Income
Deciphera Pharmaceuticals, Inc. reported Foreign Pre-Tax Income of -$3.13 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, foreign for fiscal 2023 was -$3.13M.
- Deciphera Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, foreign for fiscal 2022 was -$5.14M.
- Deciphera Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, foreign for fiscal 2021 was -$18.84M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Foreign 12 month |
|---|---|
| 2023-12-31 | -$3.13M 10-K · filed 2024-02-07 |
| 2022-12-31 | -$5.14M 10-K · filed 2024-02-07 |
| 2021-12-31 | -$18.84M 10-K · filed 2024-02-07 |